Policy development and impact assessment

As societies and technologies change, it is vital to understand and test the value of medical innovations and new care models. Our expertise in impact assessment and wider understanding of health- and social care markets enable us to advise policy-makers and funders how to prioritise policies and interventions needed to support the delivery of health and medical care. Our work includes:

Assessment of the economic, social and innovation impact of Novartis UK. We also undertook as similar study for Novartis Netherlands.
Analysis of regulatory models of telemedicine for the General Medical Council.
Assessment of the value and savings attributable to Look Ahead’s integration social care and housing model.